EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
about
Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesisReceptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migrationEph/ephrin molecules--a hub for signaling and endocytosisEphs and ephrins in cancer: ephrin-A1 signallingmTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling AxisThe ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirusCapillary defects and exaggerated inflammatory response in the airways of EphA2-deficient miceDetermination of the CD148-Interacting Region in Thrombospondin-1Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinaseEssential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesisThe transcriptome of the bowhead whale Balaena mysticetus reveals adaptations of the longest-lived mammalEphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodelingThe receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signalingCooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinaseVascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context.Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient EndotheliumThe molecular phylogeny of eph receptors and ephrin ligands.ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxisTwo distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.A role for epha2 in cell migration and refractive organization of the ocular lens.Mycobacterium tuberculosis interferes with the response to infection by inducing the host EphA2 receptor.Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors.A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.Ephrin-A1 is up-regulated by hypoxia in cancer cells and promotes angiogenesis of HUVECs through a coordinated cross-talk with eNOS.Low molecular weight protein tyrosine phosphatase isoforms regulate breast cancer cells migration through a RhoA dependent mechanism.Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts.Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.EphrinA1-EphA2 signal induces compaction and polarization of Madin-Darby canine kidney cells by inactivating Ezrin through negative regulation of RhoAEph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesisKaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.EphA2 as a target for ovarian cancer therapy.Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical studyIdentification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
P2860
Q21328694-7AF043A1-28B9-44A5-9231-A0B045F379C1Q24312704-67930232-8943-48B1-8976-5472556DFEB9Q24611588-96C110DF-BA05-4482-A9F4-E080D17CBF37Q26864889-D39FEAF9-B2F6-43C3-89C0-B1980B228A74Q27310985-DDBDD650-7299-49BB-BAEC-8A0B442C52B4Q28267511-7F1D0BFC-DD12-4E6C-90AA-1DE67E59C9BBQ28507417-EF5780B2-7DDF-4FEA-A2B6-E32D7CAAD862Q28551843-39685EE1-514B-4887-9874-AC2827903F37Q28585639-0EE2B737-1887-4DAB-8BC8-293DEEEB5C17Q28586276-9627D900-92D7-4D05-BE15-44F712B311A7Q28651042-9164AFEF-2768-42B0-A396-FFA2863B9F3EQ30479634-282CF292-754A-4095-8C11-B27F0885F3E5Q30480823-4E8BF381-451E-4E09-A089-97CB80068BB0Q30498003-FEF6E4DB-A31C-4435-9C28-2B5E14A994BCQ30514025-4189E727-C774-46DD-A278-908539B66496Q30559386-A6F1C1F1-F2E0-4AD8-BFDC-923963FD314AQ30646148-59A0F97E-3506-46C9-ACE2-B9D58B31AC03Q33336877-90D1252C-7D97-459A-86AC-40E94477D731Q33518578-B793327F-A8F7-4D40-9D04-66723C2BF1D9Q33859205-CDD8E515-7BAC-461D-8F15-C803D44A823AQ34100250-85E6F00A-4004-44E5-8635-3377A39F8C3BQ34132913-EFD802E3-8B0D-446C-9303-EB5F51E3B0DCQ34263351-50639003-2FD4-4B7E-AA0E-587F32AA7888Q34366927-AE620AC8-026E-4AEB-BD8B-DFA68E40B07AQ34512240-DB605B72-1806-4767-B376-51B3F945E2C3Q34547793-FF889EA5-174B-456C-8E18-00F632D98176Q34990038-AF1140EF-1CB1-4C70-B81B-F65B0BA248DAQ35006288-54156E3C-7D21-4FFC-9FA2-75743551ADA3Q35032526-E28EA5A7-77CB-4740-AD44-DC628C996118Q35165191-A167D962-C7E0-4F82-AE85-6CB40D0261A6Q35626109-5503890D-7A99-4312-804D-E6F5EEAE83BAQ35684746-DE2209C9-A1ED-4307-9543-588AE9457BD6Q35748107-63286D68-646A-42BC-97AC-64F1D692BE5BQ35896879-F5DEC3B0-6CEE-4A4E-9319-91463BBC5AE6Q35983048-DD1F538D-9233-42F6-948F-441AFFEAFA2AQ36103385-E0C1DDE5-419A-4743-ABD0-8DF6A86E9EE8Q36219713-8C1D8C67-463F-4EDF-B121-F8DA7918CB88Q36318535-E251E86E-3BA8-4773-AE74-CCD38AC50B52Q36576644-179F95FB-1A21-42C5-8DCD-4657A3DFA460Q36701792-3CD600F5-F5EE-4C37-8D77-B0D9E3AF70B8
P2860
EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
EphA2 receptor tyrosine kinase ...... diated Rac1 GTPase activation.
@en
EphA2 receptor tyrosine kinase ...... diated Rac1 GTPase activation.
@nl
type
label
EphA2 receptor tyrosine kinase ...... diated Rac1 GTPase activation.
@en
EphA2 receptor tyrosine kinase ...... diated Rac1 GTPase activation.
@nl
prefLabel
EphA2 receptor tyrosine kinase ...... diated Rac1 GTPase activation.
@en
EphA2 receptor tyrosine kinase ...... diated Rac1 GTPase activation.
@nl
P2093
P356
P1476
EphA2 receptor tyrosine kinase ...... ediated Rac1 GTPase activation
@en
P2093
Ambra Pozzi
Dana M Brantley-Sieders
Donna Hicks
Joseph C Ruiz
Justin Caughron
P304
P356
10.1242/JCS.01061
P407
P50
P577
2004-03-30T00:00:00Z